Cambridge Angels group
Angel networkCambridge · Pre-Seed–Series A · 9 people tracked
Investment thesis
Cambridge Angels is an invitation-only UK business angel network connecting entrepreneurs with capital and expertise from members who are largely exited entrepreneurs, often in technology and healthcare. Investing since 2001, the group has supported over 150 companies and operates a clearly defined, streamlined investment process. Membership is capped at 65 and includes several corporate venture capital members. The network levies no pitching or carry fees on companies, funding itself through membership fees and sponsorship. Rooted in the Cambridge ecosystem, the UK's 'Silicon Fen,' the group runs events and free office hours for founders, and actively works to increase diversity among its membership.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from curated & public directoriesFounder mafia
3 people who came through Cambridge Angels group went on to found or lead other companies.
What they invest in
from 103 of 133 portfolio companiesHealthtech ×36AI & Machine Learning ×33Deep Tech ×33Biotech ×30Medical Devices ×22Hardware ×21Digital Health ×19Enterprise Software ×16
HQs:United Kingdom×67Ireland×1United Kingdom×1United States×1
Who they back
founder profiles across 42 portfolio companiesFounding team size:solo founder×242 founders×113 founders×54+ founders×2
Where their founders studiedfrom 16 founders with education data
University of Cambridge ×8Cambridge Judge Business School ×2UCL ×2University of Bath ×2University of Liverpool ×2
Where their founders worked beforefrom 17 founders with career history
Weizmann Institute of Science ×2
Accelerator rootsportfolio companies that came through a program
Investments · 133 tracked
founders shown can be your intro path52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.
BiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsMeridian Health VenturesFuture Planet CapitalParkwalk AdvisorsMilltrust International Group
8power builds 'Fit & Forget' wireless sensors that provide real-time condition monitoring, data and analytics for industrial machinery such as pumps, motors and gearboxes, allowing clients to track remote asset performance and plan maintenance.
Advanced ManufacturingAI & Machine LearningCleantechEnterprise SoftwareHardwareIoTCambridge, GB
Paul Egan(CEO)Glen Clark(CFO)
BoardRichard Green(Chairman)
Co-investorsParkwalk Advisors
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.
BiotechDeep TechHardwareMedical DevicesCambridge, GB
Dr Ruizhi Wang(CEO)
Co-investorsM Ventures
stampfree.ai provides patented AI-based technology that lets individuals and retailers send and return parcels using digital codes instead of labels, printers, or apps.
AI & Machine LearningLogistics & Supply ChainRetail TechSaaS
Hugh Craigie Halkett(CEO and Founder)in
Feebris offers a clinical platform with CE-certified medical device AI (PlethAI, Class IIb) that enables hospital-grade remote patient monitoring and care at home.
AI & Machine LearningDigital HealthMedical Devices
Co-investors24 HaymarketJoyance PartnersMeridian Health VenturesSupermorpheus
CardiaTec Biosciences is a UK company working on decoding cardiovascular disease biology.
Co-investorsMontage Ventures
Co-investorsTwin Path Ventures
Albotherm develops a heat-activated coating for adaptive glazing that changes transparency in response to temperature, validated in commercial greenhouse trials and in development for the built environment, energy, and mobility surfaces.
AgTechCleantechClimate TechDeep TechNew MaterialsBristol, GB
Siân Fussell(Co-founder & CTO)Molly(Co-founder & CEO)
Co-investorsInnovate UKOxford Investment Opportunity Network (OION)Sustainable Ventures
Antiverse is a techbio company that uses machine learning and cell line engineering to design de novo antibody therapeutics against difficult targets such as G-protein coupled receptors and ion channels.
AI & Machine LearningBiotechDeep TechCardiff, GB
Ben H.(Founder)in
Co-investorsDeep Science VenturesDOMiNO VenturesFuture Planet CapitalInnospark VenturesUK Innovation & Science Seed Fund
Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics.
BiotechMedical DevicesNew Materials
Steve Swioklo(Founder)in
Co-investorsFuture Planet CapitalO2h VenturesUK Innovation & Science Seed Fund
AXOL is a biotech company backed by investors including Par Equity, Meltwind Advisory, and Scottish Enterprise.
BiotechDeep TechHealthtechRoslin, UK
Co-investorsCalculusScottish EnterpriseEMV CapitalMartlet Capital
Biiah provides a measurement and evaluation platform designed for arts and culture organizations to demonstrate the wellbeing impact of their programs.
Data & InfrastructureEdTechHealthtechImpact & Social GoodSaaSWembley, GB
Xann Schwinn(Founder & CEO)Dr. Kirsten Rennie(Chief Scientific Officer)
Co-investorsTechstars
Blu Wireless develops millimeter wave radio networking technology for wireless communications.
Deep TechDefense TechHardwareSemiconductorsBristol, GB
Anthony Murray(Chief Executive Officer)Johnny Bray(Chief Financial Officer)Dave Purle(Chief Operating Officer)Ciara Barron(Director of Marketing)Darren McNamara(Director of Technology Development)Jonathan Rogers(Director of Systems and Platforms)
Co-investorsMaven Capital PartnersSalica InvestmentsARMCalculus Capital Ltd.Wren Capital
Bugbiome develops crop protection products for farmers that aim to work with natural systems.
AgTechBiotechClimate Tech
Dr Alicia Showering(Founder)in
Co-investorsAg Ventures AllianceAgLaunch AcceleratorAvonmore DevelopmentsRockstart
Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing.
BiotechDeep TechDigital HealthMedical DevicesCambridge, GB
Hendrik Runge(Founder & CEO)Ulrich Keyser(Scientific Founder)
BoardAnthony Cooke(Chairman)John Yeomans(Director)Max Zhu(Director)
CamGene Therapeutics develops RNA-based medicines, including mRNA, siRNA, and antisense oligonucleotides delivered via lipid nanoparticles, to treat the underlying cellular dysfunction that causes hearing loss.
BiotechDeep TechHealthtechCambridge, GB
Arpan Desai(CEO & Co-founder)Prashant Shah(Co-founder)Sunil Shah(Co-founder)
Co-investorsEos AdvisoryFuture Planet CapitalUK Innovation & Science Seed Fund
Camstent develops coated medical devices using proprietary bacteriophobic polymer technology to reduce biofilm formation and infection risk on silicon-based medical devices, particularly catheters.
BiotechHealthtechMedical DevicesNew MaterialsCambridge, GB
Co-investorsEMV CapitalMartlet Capital
Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersNew Wave VenturesUTEC
Cogitat develops brain-computer interface (BCI) technology combining neuroscience and AI/ML, with work spanning neuroinformatics, data science, and XR product engineering.
AI & Machine LearningDeep TechHealthtech
Allan Ponniah(Cofounder - CEO)inDimitrios Adamos(Cofounder - CTO)inStefanos Zafeiriou(Cofounder - Scientific Lead)inNikos Laskaris(Cofounder - Neuroinformatics Lead)inIrene Kotsia(Cofounder - Data/ML Lead)inYannis Panagakis(Cofounder - AI/ML Lead)in
Co-investorsBeast Ventures
Interview with CEO Irina Babina.
Converge builds concrete monitoring and management tools for construction contractors, including embedded and reusable long-range sensors and AI-powered mix insights under its ConcreteDNA suite.
Advanced ManufacturingAI & Machine LearningConstruction TechIoTLondon, GB
Raph Scheps(CEO)inGideon Farrell(CTO)inRaphael Scheps(Founder)
Co-investorsClimate InvestmentEMV CapitalEntrepreneur FirstJ-ImpactMartlet Capital
Cotton Mouton Diagnostics operates a UKAS-accredited laboratory offering endotoxin testing services for liquid pharmaceutical products, including method development, validation, and low endotoxin recovery studies.
BiotechEnterprise SoftwareHealthtechMedical DevicesCardiff, GB
Jenna Bowen(Co-founder & Senior Executive Officer)Chris Allender(Co-founder & Chief Scientific Officer)
Co-investorsPerivoli Innovations
Co-investorsFuel Ventures
OneID provides digital identity verification and age assurance services designed to reduce friction in customer onboarding while meeting regulatory compliance requirements.
CybersecurityFintechGovTech
Cytal presents information about its investors on this page.
CybersecurityDeveloper ToolsEnterprise SoftwareSector Agnostic
Co-investorsOrigin Capital
Adora Women's Health provides clinically-led menopause and menstrual health support for employers, offering consultations, training, and education sessions as part of workplace benefits and wellbeing programs.
Digital HealthFemTechHR Tech
Co-investorsAngel AcademeNina Capital
Boutros Bear provides clinically evidenced rehabilitation and recovery programs for employees with long-term health conditions including cancer, chronic pain, menopause, and mental health issues.
HealthtechHR TechWellness & FitnessCambridge, GB
Robotics business developing AI-powered harvesting technology; raised over £14M.
Eco-Inject manufactures sustainable single-use autoinjectors for pharmaceutical applications, using a novel design that reduces component count and carbon emissions while maintaining cost parity with conventional devices.
Circular EconomyCleantechMedical Devices
Co-investorsAdjuvo
Epoch Biodesign develops enzyme recycling technology powered by AI to break down plastic and textile waste into virgin-grade chemical building blocks.
AI & Machine LearningBiotechCircular EconomyClimate Tech
Jacobin
Co-investorsExtantia CapitalMundi VenturesLowercarbon CapitalAmadeus Capital PartnersAvonmore DevelopmentsKOMPAS VC+3 more
Equisera develops RiPR (Rising Pressure Reformer), a patented modular technology that converts wet biogenic waste into clean gas using supercritical water, producing biomethane, hydrogen, captured carbon dioxide and biochar.
Circular EconomyCleantechClimate TechEnergyEastington, GB
James Milner(CEO)
Evolution AI builds AI models that combine computer vision and natural language processing to automatically extract and interpret data from documents.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechLegalTechSaaS
Martin(Chief Scientist & CEO)Rafal(CTO)
Co-investorsAI Seed
Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.
BiotechDigital HealthHealthtechMedical Devices
Olav Hellebø(Chief Executive Officer)
Co-investorsO2h VenturesWellcome TrustWren CapitalEMV CapitalMartlet CapitalStoic VC+1 more
Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases.
BiotechLongevity
William Bains(Founding scientist)
FocalPoint develops positioning and navigation technology that improves accuracy beyond radio-based systems for everyday applications.
AI & Machine LearningDeep TechHardwareIoTMobility & TransportationUK, GB
Scott Pomerantz(CEO)
Co-investorsMolten VenturesForte VenturesPassion CapitalEMV CapitalMartlet CapitalIQ Capital
Fresh4cast provides forecasting and planning software for companies in the fresh produce (fruit and vegetable) sector, aimed at improving financial and environmental sustainability.
AgTechCloud ComputingFoodTechSaaSLondon, GB
Co-investorsDraper AssociatesMetaplanet
FutureYou Cambridge develops scientifically-backed nutritional supplements for consumer health and wellness, with formulations optimized for absorption and supported by published clinical research.
ConsumerDirect to ConsumerHealthtechLongevityWellness & FitnessCambridge, GB
Gabriela Peacock(Founder, GP Nutrition)Max Gowland(Chief Scientific Officer)Miriam Ferrer(Head of Product Development)
BoardAidan Goggins(Nutritionist and author)
GetScanned is a UK platform that allows patients to book private MRI scans directly without GP referrals, comparing options across scanning centres for convenient scheduling.
Digital HealthHealthtechUK, GB
Hammer Missions provides AI-powered inspection software that helps engineers and asset owners inspect and assess buildings and infrastructure.
AI & Machine LearningConstruction TechDeep Tech
Makesense Technology develops navigation technology for people with visual impairments, enabling independent outdoor mobility.
Deep TechDigital HealthImpact & Social Good
Co-investorsEka Ventures
Healx is an AI-powered biotech company that discovers and develops treatments for rare diseases.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Tim Guilliams(Co-founder & CEO)in
Co-investorsAmadeus Capital PartnersBalderton CapitalIntel CapitalSCI Ventures
Cambridge company whose AI-powered heart failure home-monitoring device received FDA Breakthrough Device Designation.
Higlo builds technology and a hardware device ("Hearth") designed for families to share and stay connected across distances, using one shared account for all ages rather than individual-focused products.
ConsumerHardwareSocial
Co-investorsTechstart Ventures
HotHouse Therapeutics uses artificial intelligence and synthetic biology to reprogram plant biosynthetic pathways to create novel pharmaceutical compounds not achievable through traditional chemical synthesis.
AI & Machine LearningBiotechDeep TechNorwich, GB
Professor Anne Osbourn OBE FRS FLS(Chief Science Officer)Dr David Sheppard(Chief Executive Officer)
Co-investorsFuture Planet CapitalTwin Path VenturesUK Innovation & Science Seed Fund
Hybrid Access Technologies provides multi-link connectivity software, including SD-WAN thin-client and link-bonding technology that combines multiple network connections (broadband, 4G/5G, satellite, FWA, FTTP) into a single virtual pipe.
Cloud ComputingEnterprise SoftwareIoTSaaS
Paul Evans(Founder & CEO)
Mindler (previously ieso) provides one-to-one, therapist-delivered text-based cognitive behavioural therapy (CBT) delivered online to patients, using de-identified therapy data and analysis to inform treatment.
Digital HealthHealthtechMental Health
Co-investorsEMV CapitalMartlet CapitalMolten Ventures
Developing battery technology; interview with Christoph Schnedermann.
Kalium Health is developing personalised, at-home health monitoring for chronic kidney disease, aimed at helping healthcare providers and patients track key risks to improve outcomes and reduce costs.
Digital HealthHealthtechMedical DevicesCambridge, GB
Fiona Karet(Chief Medical Officer)
Co-investorsMartlet CapitalEMV Capital
Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates.
AI & Machine LearningBiotechDeep Tech
Co-investorsAI SeedBeresford Ventures
Library of Things is a social enterprise that rents household tools and equipment from local self-service lockers, offering users access to high-quality items from brands like Bosch and Stihl while promoting circular consumption and reducing waste.
B2B MarketplacesCircular EconomyConsumerLondon, GB
CyberSmart provides cybersecurity monitoring, training, and insurance solutions designed for small and medium-sized enterprises and the organizations that serve them.
CybersecurityEnterprise SoftwareInsurTechSaaSLondon, GB
Co-investorsKickstart InnovationOxxIQ Capital
MNS (Microneedle Solutions) develops medical technology based on microneedle systems, with stated aims of reducing health disparities and improving access to quality healthcare.
BiotechHealthtechMedical DevicesLeeds, GB
MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy.
BiotechDeep TechHealthtech
Co-investorsLongwall Venture Partners LLP
Reducing barriers to vaccination and delivering NHS savings.
Molymem develops membrane technologies based on 2D materials to address water and air filtration challenges.
CleantechDeep TechNew MaterialsManchester, GB
Mark Bissett(Academic Co-founder)inRobert Drye(Co-founder)Robert Dryfe(Founder & CSO)inRob Dryfe(Academic Co-founder)Ray Gibbs(CEO)inPaul Wiper(COO)in
Co-investorsGC Angels
mOm develops the mOm Essential, a neonatal incubator that warms newborns to normal body temperature to prevent hypothermia and avoidable NICU admissions.
HardwareHealthtechMedical DevicesEdinburgh, GB
James Roberts(CEO, Co-Founder & Board)Richard Marlow(CFO (Board))Daniel Green(Chief Operating Officer)
Co-investorsConduit ConnectCross-Border Impact Ventures
Netronome develops heterogeneous processing solutions for data center networking, including programmable silicon architectures and board-level SmartNIC products that offload networking and security functions from x86 processors.
Cloud ComputingData & InfrastructureHardwareSemiconductorsSanta Clara, US
Jan Niel Viljoen(Executive Officer, Director)Niel Viljoen(CEO and Founder)Perry J. Grace(Executive Officer)Perry Grace(CFO)Jim Finnegan(COO)Sean Maloney(Director)
Co-investorsCisco Investments
NexusAM provides AI-powered real-time monitoring and predictive intelligence software for metal additive manufacturing, targeting qualification cost reductions and process optimization.
Advanced ManufacturingAI & Machine LearningDeep Tech
Co-investorsAvonmore Developments
NK:IO develops natural killer (NK) cell and small molecule therapies for cancer, targeting both haematological and solid tumours such as ovarian cancer.
BiotechDeep TechHealthtechLondon, GB
Hugh Brady(Co-founder)Matthew J. Fuchter(Co-founder)Andrew Baxendalein
Co-investorsFuture Planet CapitalUK Innovation & Science Seed Fund
NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials.
AgTechBiotechHealthtechNew Materials
Co-investorsAdjuvoEMV CapitalMartlet CapitalThe Yield Lab EuropeThe Yield Lab
Orthofuse designs orthopedic implants and surgical systems using 3D printing technology for trauma and spinal procedures.
Advanced ManufacturingDeep TechMedical Devices
Co-investorsAvonmore Developments
Oxford Space Systems designs and manufactures deployable antennas for satellites, focused on reducing mass and improving stowage efficiency and performance.
Deep TechHardwareSpace TechHarwell, GB
Sean Sutcliffein
Co-investorsEMV CapitalFuture Planet CapitalLongwall Venture Partners LLPMartlet CapitalOxford Investment Opportunity NetworkOxford Investment Opportunity Network (OION)+4 more
Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.
Deep TechNew MaterialsSemiconductorsCambridgeshire
Simon Thomas(Chief Executive Officer of the issuer.)
Co-investorsAmadeus Capital PartnersBlack Opal VenturesEMV CapitalIn-Q-TelIQ CapitalMartlet Capital+4 more
Pathfinder Med develops its patented ePATH catheter guidance platform for endovascular procedures in peripheral interventions and vascular access creation.
HardwareHealthtechMedical DevicesLondon, GB
Dr. Lorenzo Patrone(Chief Medical Officer)
Co-investorsDeepbridge Capital
PatientSource provides a cloud-based diagnostic testing module for healthcare settings that manages radiology, pathology, cardiology, and other clinical tests.
AI & Machine LearningCloud ComputingDigital HealthHealthtechSaaSCambridge, GB
Dr Michael Brooks(Founder)Dr Philip Ashworth(Founder)Lee Francis(Co-founder, Sales, Marketing and Partnerships Director)Phil McSweeney(Executive Chair)
Co-investorsEMV Capital
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Co-investorsMartlet CapitalMC Healthcare VenturesO2h VenturesWren Capital
PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.
BiotechMedical DevicesCambridge, GB
Co-investorsAmadeus Capital PartnersAstellas Venture Management LLCUniversity of Cambridge Enterprise
Plinth is an organization focused on social impact, technology, and community development that offers expert speakers on topics including government innovation, charity sector technology, and digital storytelling for marginalized communities.
AI & Machine LearningGovTechImpact & Social GoodSaaSSocial
Plumis designs and manufactures intelligent water mist fire suppression systems for domestic and commercial use that detect fires earlier and deliver more effective outcomes than conventional sprinkler systems.
CleantechConstruction TechDeep TechHardwareIoTPropTech
William Makant(Co-founder and CEO)
Co-investorsEMV Capital
PneumaCare develops Structured Light Plethysmography (SLP) technology and markets Thora-3Di, a non-contact, non-invasive 3D-imaging device for lung function assessment used in paediatric, ICU, and thoracic surgery hospital settings.
Digital HealthHealthtechMedical DevicesCambridge, GB
Bart A. Lewin(Chief Executive Officer)
Pometry provides a temporal graph database platform with AI infrastructure tools for querying and analyzing time-aware data across business, technical, and AI agent contexts.
AI & Machine LearningData & InfrastructureEnterprise Software
Co-investorsAlbionVCCrane Venture PartnersUCL Technology Fund
Porotech develops MicroLED display technology, supplying components and technology consultancy to help partners manufacture microLED displays.
Deep TechHardwareSemiconductors
Co-investorsIQ CapitalMartlet CapitalSpeedinvest
Co-investorsAvonmore DevelopmentsDebiopharm Innovation FundDeep Science VenturesOncology Ventures
Psyomics builds behavioral health assessment tools, including beseen™, which captures structured data and free text from patients, families, and professionals to support clinical pathways for adults and young people.
Digital HealthHealthtechMental Health
Dr. Melinda Rees(Chief Executive Officer)inRupert Hipwell(Chief Commercial Officer)inAlex Nancekievill(Chief Technology Officer)in
Co-investorsEMV CapitalMartlet Capital
Qkine manufactures and supplies high-purity growth factors and cytokines for research and therapeutic applications, serving life sciences researchers and cell therapy developers.
BiotechDeep TechHealthtechNew MaterialsCambridge, GB
Dr Marko Hyvönen(CSO & Founder)
Co-investorsEMV CapitalMartlet CapitalOxford Investment Opportunity Network (OION)
Qureight is a UK AI-powered imaging CRO providing enterprise-grade imaging and precision endpoints for lung and heart disease trials.
Muhunthan Thillai(Founder)in
Co-investorsGuinness VenturesMolten VenturesPlayfair CapitalXTX Markets
Cellulose-based sustainable colorants for fashion, cosmetics, and packaging.
Co-investorsEMV CapitalMartlet CapitalSustainable VenturesAda Ventures
RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
BiotechDigital HealthHealthtechMedical Devices
Piers Kotting(Chief Executive Officer)Simon Allocca(Chief Financial Officer)
Co-investorsAnglia Capital Group
Entered a strategic partnership with cybersecurity provider CyberSmart.
RiskTech builds an operational intelligence platform that uses AI and automation to help venue and building operators prevent incidents, reduce risk, and support insurance claim defensibility.
AI & Machine LearningEnterprise SoftwareInsurTechPropTechCork, IE
RoboK offers SiteLens®, an AI computer vision platform that analyzes existing CCTV footage to detect workplace hazards, monitor PPE compliance, identify near misses, and generate safety KPI and compliance reports.
Advanced ManufacturingAI & Machine LearningLogistics & Supply Chain
Co-investorsEMV CapitalMartlet Capital
Dogtooth develops commercial robotic harvesting systems for soft fruit growers operating in glasshouses and polytunnels.
AgTechHardwareRobotics
Sano provides a platform combining genetic testing, patient recruitment, and engagement tools for precision medicine clinical trials.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Patrick Short(CEO)inCharlotte Guzzo(COO)William Jones(CTO)
Co-investorsEpisode1January VenturesMMC Ventures
ScaleXP is an AI-powered finance platform that automates revenue recognition, billing, subscription management, and month-end close by connecting accounting, billing, and CRM systems into one source of truth.
AI & Machine LearningFintechSaaS
Co-investorsAngel AcademeFounders Factory
SeeChange provides a computer vision AI platform that processes data from physical sensors (cameras, scanners, scales) to generate actionable alerts for retail and security environments.
AI & Machine LearningCloud ComputingEnterprise SoftwareRetail Tech
Co-investorsCrane Venture PartnersPortfolio VenturesRuna CapitalTriple Point VenturesTrue Capital Management
Co-investorsOctopus VenturesCambridge Innovation Capital
Signaloid develops UxHw technology, a compute platform that propagates uncertainty by evaluating a distribution of inputs in a single program execution to produce distribution-based results.
AI & Machine LearningDeep TechHardwareSemiconductors
Phillip(Founder, CEO/CTO)
Co-investorsEMV CapitalIQ CapitalMartlet CapitalType One Ventures
Silveray develops flexible X-ray detectors using patented semiconductor ink technology for non-destructive testing in industrial applications including oil and gas, nuclear energy, aerospace, and shipbuilding.
Advanced ManufacturingDeep TechHardwareStockport, GB
Co-investorsFuture Planet CapitalUK Innovation & Science Seed FundNorthern Gritstone
Singular Photonics develops digital image sensors based on single-photon avalanche diode (SPAD) technology, which convert photons directly into digital signals to capture depth and temporal data as 4D images.
Deep TechHardwareMedical DevicesSemiconductors
Co-investorsACF InvestorsOld College CapitalScottish EnterpriseWren Capital
Solvemed develops a smartphone-based FDA-cleared medical device for pupil size and reactivity testing in neurological exams, eliminating the need for separate hardware.
AI & Machine LearningHealthtechMedical Devices
Michal Wlodarski, PhD(Founder)inHugo Chrost(Founder)in
Co-investorsFf Venture CapitalSunfish PartnersTechniVentures
Sorex Sensors develops film bulk acoustic resonator (FBAR) technology for sensor applications in semiconductor markets.
Deep TechHardwareHealthtechIoTSemiconductors
Michael LeGoff(Executive Chairman)
Co-investorsEMV CapitalMartlet Capital
Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases.
BiotechDeep TechHealthtech
Myriam Ouberai(Founder)Bo Rode Hansen(Executive Director)
Co-investorsStart Codon
Spotta builds IoT-based pest detection systems that automatically monitor for insects such as bed bugs, red palm weevil, and forestry pests.
AgTechAI & Machine LearningHardwareIoTCambridge, GB
Robert Fryers(Founder & CEO)inNeil D'Souza-Mathew(Founder & CTO)inRob Alner(COO)inMike Payne(Finance Director)
Co-investorsBayes Entrepreneurship FundEMV CapitalMartlet CapitalREMUS CapitalThe Yield Lab EuropeThe Yield Lab
Stemnovate provides an integrated platform combining multiomics data, cell reprogramming technology, and mechanistic functional studies to accelerate drug discovery and clinical translation for rare diseases, neurodegenerative conditions, and other therapeutic areas across human and animal health.
AI & Machine LearningBiotechDeep Tech
SyndicateRoom operates tax-efficient EIS and SEIS investment funds that let investors build diversified portfolios of early-stage UK startups by co-investing alongside experienced angel investors.
Fintech
Co-investorsAngel Academe
Techspert recruits life sciences and healthcare experts for qualitative and quantitative research projects, using AI-powered tools to automate interview scheduling, transcription, and data capture for market research firms and biotech companies.
AI & Machine LearningHealthtechMarketing Tech
Co-investorsInnvotec Ltd.Martlet CapitalOxford Investment Opportunity Network (OION)
Tenyks develops a Visual Intelligence Platform that processes and extracts actionable insights from large collections of visual data and assets.
AI & Machine LearningData & InfrastructureEnterprise SoftwareRetail TechCambridge, GB
Botty Dimanov(Founder)in
Co-investorsRKKVCY Combinatorfirstminute capitalLAUNCHub VenturesSpeedinvest
Co-investorsOxford Investment Opportunity Network (OION)
Thought Machine builds cloud-native core banking technology designed to run in public, private, and hybrid cloud environments for banks migrating off legacy core systems.
Cloud ComputingEnterprise SoftwareFintechSaaSLondon, GB
Paul Taylor(Founder & CEO)
Co-investorsLloyds Banking GroupAir Street CapitalBackedKarma VenturesMolten VenturesNyca+6 more
TransparentChoice provides a project portfolio prioritization system combining a criteria-based decision framework, a portfolio management platform, and expert PMO advisory support.
Enterprise SoftwareSaaS
Co-investorsEMV CapitalMartlet Capital
UnlikelyAI builds AI technology designed to support real-world decision-making through interpretable and trustworthy models.
AI & Machine LearningEnterprise Software
Co-investorsAmadeus Capital PartnersCambridge Innovation CapitalMetaplanetMS&AD VenturesOctopus Ventures
Verinnogen develops data collection technology for pre-clinical cancer research, aiming to improve the accuracy, repeatability, and reliability of research data.
BiotechHealthtechMedical Devices
Dr Isaac Johnson(Co-founder & CEO)Dr Mike Irvine(Co-founder & CTO)
Co-investorsStart Codon
Verisian builds software for clinical research and public health authorities to analyze and monitor clinical trial data in real-time, improving decision-making and trial safety.
BiotechDigital HealthHealthtechSaaS
BoardSunil Gupta(Strategic Advisor)
Co-investorsRecode VenturesSuperSeed
ViaNautis develops targeted polyNaut nanovesicle (tPNV) delivery technology to advance cell and gene therapies and genetic medicines.
BiotechDeep TechMedical DevicesCambridge, GB
Co-investorsOxford Investment Opportunity Network (OION)
Vitrue Health provides personalized healthcare pathways to help stabilize healthcare costs, focusing on musculoskeletal pain management.
AI & Machine LearningEnterprise SoftwareHealthtechHR TechWellness & FitnessLondon, GB
Co-investorsMMC VenturesSalica InvestmentsSimplyhealth VenturesTechstars
VividQ develops computational holography software, including an end-to-end holographic software framework and algorithms for high-quality holographic displays.
Deep TechGamingHardwareCambridge, GB
Aleksandra PedraszewskaTom Durrantin
Co-investorsUTECUTokyo Innovation Platform Co. Ltd.Sure Valley Ventures
Wazoku is a London-based innovation management company combining an AI platform with the Innocentive open-innovation solver marketplace.
Simon Hill(Founder)inRosemarie Diegnan(Founder)in
Co-investorsCalculus Capital Ltd.Octopus VenturesSaaS Capital
Co-investorsAngel Academe
Co-investorsOxford Investment Opportunity Network (OION)SyndicateRoomThe FSE Group
Xampla is a materials innovation company that develops Morro plant-based polymer materials as biodegradable, home-compostable alternatives to polluting plastics.
Circular EconomyDeep TechNew MaterialsCambridge, GB
Tuomas Knowles(Professor / Founder)Marc Rodriguez(CTO)Marc Rodríguez Garciain
Co-investorsAmadeus Capital PartnersAvonmore DevelopmentsEmerald Technology Ventures AgEMV CapitalHorizons VenturesMartlet Capital+3 more
xWatts is an intelligent energy management platform that connects to building energy systems, models facilities in real time, and automatically optimizes assets like HVAC, solar, and CHP engines to reduce energy costs and emissions in large, complex estates and industrial facilities.
CleantechClimate TechEnergyEnterprise SoftwarePropTech
Yigit Akar(Co-founder & CEO)inAlex Allen(Co-founder & CPO)Alexander A.(Founder)in
Co-investorsAntlerR42Plug and Play Ventures
Zero Gravity runs a platform and community that helps students from low-opportunity backgrounds progress into university and careers, connecting them with employers who identify, up-skill and recruit this talent.
EdTechFuture of WorkImpact & Social Good
ZeroRISC provides end-to-end security for open-source silicon, covering chip design-time IP, factory provisioning, and lifecycle/fleet management built on an open-source silicon root of trust.
CybersecurityHardwareSemiconductors
Co-investorsAvonmore DevelopmentsFontinalis Partners
Portfolio news
latest coverage across their companiesCamGene Therapeutics · cambridgeindependent.co.uk · Aug 20, 2026
Singular Photonics · eu-startups.com · Aug 19, 2026
Cambridge · eu-startups.com · Aug 10, 2026
Thought Machine · thesaasnews.com · Jul 8, 2026
Frequently asked questions
- How many investments has Cambridge Angels group made?
- Cambridge Angels group has 134 tracked investments.
- What stage does Cambridge Angels group invest at?
- Cambridge Angels group invests at the Pre-Seed, Seed, Series A stages.
- What is Cambridge Angels group's typical check size?
- Cambridge Angels group typically writes checks of $195K – $1.9M.
- What sectors does Cambridge Angels group focus on?
- Cambridge Angels group focuses on Biotech, Deep Tech, Sector Agnostic.
- Where is Cambridge Angels group located?
- Cambridge Angels group is headquartered in Cambridge, GB.
- Who does Cambridge Angels group co-invest with?
- Cambridge Angels group most often shares deals with Martlet Capital, EMV Capital, Avonmore Developments, among 111 tracked co-investors.
Images
Co-investors · 12
Balderton Capital is a European venture capital firm that backs technology startups.
Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.
Dawn Capital is a European venture capital firm backing companies with global ambitions.
Fifty Years (50Y) is a pre-seed and seed-focused venture capital firm that backs founders using technology to solve major global problems, and also helps start companies.
Kindred Capital is a London-based venture capital firm that backs early-stage founders, emphasizing a team-oriented, partnership approach to supporting companies over the long term.
Avalanche is a private investment firm led by Katelyn Donnelly that invests early in technology companies at structural inflection points, pairing capital with operational experience in complex markets like government, energy, and critical infrastructure.
Amino Collective is an early-stage venture firm that backs bold, unconventional founders willing to explore uncharted territory.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Cerulean Ventures is a venture capital firm that backs founders using AI to digitize and transform traditionally under-digitized physical-world industries such as manufacturing, supply chains, maritime, food and agriculture, and energy.
Berkeley SkyDeck is UC Berkeley's accelerator and associated fund, formed as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, offering startups accelerator resources, advisors, industry partners, and access to accredited investors.
A mental health therapeutics-focused investment fund.
Selvedge Venture is a healthcare-focused venture investor backing founders and startups working to reduce the burden of age-related medical conditions.
Firms observed investing alongside Cambridge Angels group, from public investor directories. Shared companies are the overlap with Cambridge Angels group's recorded portfolio.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Hoxton Ventures is an early-stage venture capital firm that backs pre-seed and seed companies, often investing before revenue or product and offering hands-on support to founders.





















































.jpeg)